Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lung Transplantation
100%
Cystic Fibrosis
100%
Ethical Issues
100%
Elexacaftor-tezacaftor-ivacaftor
100%
End-stage Lung Disease
100%
Cystic Fibrosis Transmembrane Conductance Regulator
50%
Clinical Decision-making
33%
Moral Obligation
16%
Treatment Options
16%
Older children
16%
Gene Function
16%
Decision-making Process
16%
Participatory Decision-making
16%
Lack of Data
16%
Family Values
16%
Letting
16%
Fibrosis Diseases
16%
Cystic Fibrosis Foundation
16%
Ethical Principles
16%
Young Patients
16%
Team Participation
16%
Modulator Therapy
16%
Matched Donor
16%
Nonmaleficence
16%
Shared Decision-making
16%
Gene Modulators
16%
Treatment Start
16%
Donor Lung
16%
Shared Decision-making Model
16%
Highly Effective Modulator Therapy
16%
Medicine and Dentistry
Cystic Fibrosis
100%
Silo-Filler's Disease
100%
Lung Transplantation
100%
Ivacaftor
100%
Tezacaftor
100%
Cystic Fibrosis Transmembrane Conductance Regulator
50%
Regulator Gene
50%
Decision Making
33%
Shared Decision Making
33%
Clinical Decision Making
33%
Diseases
33%
Gene Function
16%
Patient with Cystic Fibrosis
16%
Matched Donor
16%
Lung
16%
Treatment Option
16%
Long-Term Outcome
16%
Neuroscience
Cystic Fibrosis
100%
Ivacaftor
100%
Decision-Making
85%
Cystic Fibrosis Transmembrane Conductance Regulator
42%
Regulator Gene
42%
Decision-Making Process
14%
Gene Function
14%
Social Sciences
Diseases
100%
Ethical dilemmas
100%
Decision Making
75%
Shared Decision Making
50%
Decision-Making Process
25%